AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31872340 — intervention group
Group type: COMPARATOR
Intervention: Nutrition and exercise simultaneously (Group A)
Number of subjects: 88
Study 31872340 — intervention group
Group type: COMPARATOR
Intervention: Nutrition first (Group B)
Number of subjects: 88
Study 31474410 — intervention group
Group type: EXPERIMENTAL
Intervention: 12+ months DAPT
Number of subjects: 12162
Study 31474410 — intervention group
Group type: COMPARATOR
Intervention: 12 months DAPT
Number of subjects: 12162
Study 31474410 — intervention group
Group type: EXPERIMENTAL
Intervention: 12+ months DAPT (high DAPT score)
Number of subjects: 12162
Study 31474410 — intervention group
Group type: COMPARATOR
Intervention: 12 months DAPT (high DAPT score)
Number of subjects: 12162
Study 31474410 — intervention group
Group type: EXPERIMENTAL
Intervention: 12+ months DAPT (low DAPT score)
Number of subjects: 12162
Study 31474410 — intervention group
Group type: COMPARATOR
Intervention: 12 months DAPT (low DAPT score)
Number of subjects: 12162
Study 31474410 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical events (MI + bleeding) 12+ months DAPT
Number of subjects: 12162
Study 31474410 — intervention group
Group type: COMPARATOR
Intervention: Overall clinical events (MI + bleeding) 12 months DAPT
Number of subjects: 12162
Study 27381040 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based healthcare system for diabetes management for six months
Number of subjects: 484
Study 27381040 — intervention group
Group type: COMPARATOR
Intervention: Usual outpatient management for six months
Number of subjects: 484
Study 27381040 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based healthcare system for diabetes management for six months (subgroup with baseline HbA1c > 8%)
Number of subjects: 484
Study 25814193 — intervention group
Group type: EXPERIMENTAL
Intervention: HVT to the atlanto-axial segment (n = 11)
Number of subjects: 23
Study 25814193 — intervention group
Group type: COMPARATOR
Intervention: Pre-manipulative hold position (Control group, n = 12)
Number of subjects: 23
Study 23660210 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-related PTSD group (n = 18)
Number of subjects: 58
Study 23660210 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent SARS patients without PTSD (n = 26)
Number of subjects: 58
Study 23660210 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects (n = 18)
Number of subjects: 58
Study 21123087 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention (2-day workshop + written materials)
Number of subjects: 185
Study 21123087 — intervention group
Group type: COMPARATOR
Intervention: Written materials alone
Number of subjects: 185
Study 19446205 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic plus ketamine (LAK)
Number of subjects: 50
Study 19446205 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic alone (LAA)
Number of subjects: 50
Study 17241499 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine infusion
Number of subjects: 60
Study 17241499 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline infusion
Number of subjects: 60
Study 15515877 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose insulin regimen (1 IU/h)
Number of subjects: 40
Study 15515877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11527675 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (30 g/d)
Number of subjects: 13
Study 11527675 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13
Study 9764549 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin estolate at 40 mg/kg/day in two divided doses
Number of subjects: 302
Study 9764549 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin at 50 mg/kg/day in two divided doses
Number of subjects: 302
Study 9764549 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin estolate
Number of subjects: 302
Study 9764549 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 302
Study 29460262 — intervention group
Group type: EXPERIMENTAL
Intervention: Calm voice stimuli
Number of subjects: 20
Study 29460262 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbulent voice stimuli
Number of subjects: 20
Study 28409379 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic approach
Number of subjects: 14
Study 28409379 — intervention group
Group type: COMPARATOR
Intervention: Open surgical approach
Number of subjects: 14
Study 24836472 — intervention group
Group type: EXPERIMENTAL
Intervention: Double gloves with outer pair removed after verified intubation
Number of subjects: 41
Study 24836472 — intervention group
Group type: COMPARATOR
Intervention: Single gloves
Number of subjects: 41
Study 22931923 — intervention group
Group type: EXPERIMENTAL
Intervention: Broadband light (BBL) treatment
Number of subjects: 0
Study 22931923 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 19331437 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate/ezetimibe
Number of subjects: 60
Study 19331437 — intervention group
Group type: COMPARATOR
Intervention: Fenofibrate
Number of subjects: 60
Study 19331437 — intervention group
Group type: COMPARATOR
Intervention: Ezetimibe
Number of subjects: 60
Study 17709798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 1 mg/day
Number of subjects: 210
Study 17709798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg/week
Number of subjects: 210
Study 17709798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 5 mg/day
Number of subjects: 210
Study 17709798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 17709798 — intervention group
Group type: COMPARATOR
Intervention: Both placebos
Number of subjects: 210
Study 15010407 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 57
Study 15010407 — intervention group
Group type: COMPARATOR
Intervention: Esophageal Tracheal Combitube (ETC)
Number of subjects: 57
Study 11587974 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 142
Study 11587974 — intervention group
Group type: COMPARATOR
Intervention: Conservative Treatment (CT) - sleep hygiene and weight loss
Number of subjects: 142
Study 9842079 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Intervention (MI)
Number of subjects: 54
Study 9842079 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Intervention (AI)
Number of subjects: 54
Study 7856197 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical compression stockings (Thrombo+Sigvaris 503)
Number of subjects: 50
Study 7856197 — intervention group
Group type: COMPARATOR
Intervention: Short stretch bandages (Rosidal K)
Number of subjects: 50
Study 2791799 — intervention group
Group type: EXPERIMENTAL
Intervention: Mealtime regimen (400 mg three times a day with meals)
Number of subjects: 141
Study 2791799 — intervention group
Group type: COMPARATOR
Intervention: Bedtime regimen (1200 mg at bedtime)
Number of subjects: 141
Study 2791799 — intervention group
Group type: COMPARATOR
Intervention: Reference regimen (200 mg three times a day with meals and 600 mg at bedtime)
Number of subjects: 141
Study 338025 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (10 ml by intravenous infusion)
Number of subjects: 59
Study 338025 — intervention group
Group type: COMPARATOR
Intervention: Placebo (29 patients)
Number of subjects: 59
Study 31635844 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Sodium Hypochlorite (NaOCl)
Number of subjects: 27
Study 31635844 — intervention group
Group type: EXPERIMENTAL
Intervention: 15.5% Ferric Sulfate (FS)
Number of subjects: 27
Study 31635844 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 27
Study 31635844 — intervention group
Group type: COMPARATOR
Intervention: Indirect Pulp Therapy (IPT)
Number of subjects: 27
Study 30945034 — intervention group
Group type: EXPERIMENTAL
Intervention: MC4R SNPs (rs17782313, rs633265, rs1350341, rs12970134)
Number of subjects: 927
Study 30945034 — intervention group
Group type: EXPERIMENTAL
Intervention: GG genotype carriers of rs1350341
Number of subjects: 927
Study 27250495 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginally low Se-B (40-59 μg/l)
Number of subjects: 172
Study 27250495 — intervention group
Group type: COMPARATOR
Intervention: Optimal Se-B (≥80 μg/l)
Number of subjects: 172
Study 27250495 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal Se-B (60-79 μg/l)
Number of subjects: 172
Study 27250495 — intervention group
Group type: COMPARATOR
Intervention: All participants
Number of subjects: 172
Study 25285989 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical and psychosocial intervention program (12 weeks)
Number of subjects: 174
Study 25285989 — intervention group
Group type: COMPARATOR
Intervention: Non-participation
Number of subjects: 174
Study 25285989 — intervention group
Group type: COMPARATOR
Intervention: Distance from home to hospital
Number of subjects: 174
Study 23800438 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental concentration (low stress condition)
Number of subjects: 60
Study 23800438 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental concentration with psychosocial stress (high stress condition)
Number of subjects: 60
Study 23800438 — intervention group
Group type: COMPARATOR
Intervention: Baseline resting seated posture
Number of subjects: 60
Study 21539106 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with angle dilatation
Number of subjects: 80
Study 21539106 — intervention group
Group type: COMPARATOR
Intervention: Sinusotrabeculectomy (Control)
Number of subjects: 80
Study 19321587 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/d of isoflavones
Number of subjects: 406
Study 19321587 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg/d of isoflavones
Number of subjects: 406
Study 19321587 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study 17589924 — intervention group
Group type: EXPERIMENTAL
Intervention: GeneVac-B
Number of subjects: 158
Study 17589924 — intervention group
Group type: EXPERIMENTAL
Intervention: Engerix B
Number of subjects: 158
Study 17589924 — intervention group
Group type: EXPERIMENTAL
Intervention: Shanvac B
Number of subjects: 158
Study 15106685 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg diazepam
Number of subjects: 20
Study 15106685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11166746 — intervention group
Group type: EXPERIMENTAL
Intervention: Joel-Cohen incision, one-layer locked uterine suture, no peritoneization
Number of subjects: 158
Study 11166746 — intervention group
Group type: COMPARATOR
Intervention: Pfannenstiel incision, double layer closure of the uterus, visceral and parietal peritoneization
Number of subjects: 158
Study 11166746 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 158
Study 9750706 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (M) 30 mg.kg‐1 over 1 hour, followed by 5.4 mg.kg‐1.h‐1 for 23 hours
Number of subjects: 106
Study 9750706 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine (N) 0.015 mg.kg‐1.h‐1 over 2 hours followed by 0.03 mg.kg‐1.h‐1 for 7 days
Number of subjects: 106
Study 9750706 — intervention group
Group type: EXPERIMENTAL
Intervention: Both M and N (MN)
Number of subjects: 106
Study 9750706 — intervention group
Group type: COMPARATOR
Intervention: No medical treatment (P)
Number of subjects: 106
Study 7831600 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock-wave lithotripsy (ESWL)
Number of subjects: 10
Study 7831600 — intervention group
Group type: COMPARATOR
Intervention: Mechanical lithotripsy (Control)
Number of subjects: 10
Study 3417466 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to relaxation-type music
Number of subjects: 75
Study 3417466 — intervention group
Group type: COMPARATOR
Intervention: White noise
Number of subjects: 75
Study 3417466 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music or white noise)
Number of subjects: 75
Study 3417466 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (music and white noise)
Number of subjects: 75
Study 31099632 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm (new anticancer drugs)
Number of subjects: 0
Study 31099632 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard treatment)
Number of subjects: 0
Study 27914033 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine 2 g/day plus simvastatin 20 mg/day
Number of subjects: 58
Study 27914033 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus simvastatin 20 mg/day
Number of subjects: 58
Study 25782065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional distraction (listening to music) during a 12-min running test
Number of subjects: 53
Study 25782065 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional distraction (listening to music) during a 20-min exercise session
Number of subjects: 53
Study 25782065 — intervention group
Group type: COMPARATOR
Intervention: No attentional distraction during a 12-min running test
Number of subjects: 53
Study 25782065 — intervention group
Group type: COMPARATOR
Intervention: No attentional distraction during a 20-min exercise session
Number of subjects: 53
Study 23106262 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental theory intervention (6 sessions)
Number of subjects: 230
Study 23106262 — intervention group
Group type: COMPARATOR
Intervention: Coping skills control group
Number of subjects: 230
Study 23106262 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 230
Study 21354368 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (0.125-0.75 mg/d)
Number of subjects: 331
Study 21354368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study 18500518 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg p.o. alone
Number of subjects: 12
Study 18500518 — intervention group
Group type: COMPARATOR
Intervention: Imatinib 400 mg p.o. with 20 mL antacid (1.6 g Al(OH)(3) + 1.6 g Mg(OH)(2)) 15 min before imatinib
Number of subjects: 12
Study 17413095 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal calcium intake (1 g/d) during weight loss
Number of subjects: 44
Study 17413095 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium intake (1.8 g/d) during weight loss
Number of subjects: 44
Study 17413095 — intervention group
Group type: COMPARATOR
Intervention: Weight maintenance group (1 g Ca/d)
Number of subjects: 44
Study 15465449 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative driving phases
Number of subjects: 14
Study 15465449 — intervention group
Group type: EXPERIMENTAL
Intervention: Waxing phases
Number of subjects: 14
Study 15465449 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall EEG activity
Number of subjects: 14
Study 12577419 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus injection (ASI) 20 ml in 500 ml 5% glucose solution, once a day for 2 months
Number of subjects: 76
Study 12577419 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard anti-tuberculosis regimen HRE (S)Z or KHZ1321 TH)
Number of subjects: 76
Study 9701408 — intervention group
Group type: EXPERIMENTAL
Intervention: SR 48968 (100 mg)
Number of subjects: 12
Study 8055885 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) beverage
Number of subjects: 0
Study 8055885 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) beverage
Number of subjects: 0
Study 2918321 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive frame (probability of survival given)
Number of subjects: 283
Study 2918321 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative frame (probability of dying given)
Number of subjects: 283
Study 2918321 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed frame (both probabilities given)
Number of subjects: 283
Study 2918321 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 283
Study 4615595 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 7‐0207
Number of subjects: 115
Study 4615595 — intervention group
Group type: COMPARATOR
Intervention: metronidazole
Number of subjects: 115
Study 31897483 — intervention group
Group type: EXPERIMENTAL
Intervention: Multinutrient supplementation (14 g l-arginine, 14 g l-glutamine, 1250 mg vitamin C, 55 mg zinc daily for 14 days before and after surgery)
Number of subjects: 21
Study 31897483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no multinutrient supplementation)
Number of subjects: 21
Study 31897483 — intervention group
Group type: EXPERIMENTAL
Intervention: Multinutrient supplementation
Number of subjects: 21
Study 31897483 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study 31002583 — intervention group
Group type: COMPARATOR
Intervention: Dapivirine vaginal ring
Number of subjects: 1261
Study 30098917 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZA)
Number of subjects: 50
Study 26902850 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil
Number of subjects: 81
Study 26902850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 24595577 — intervention group
Group type: EXPERIMENTAL
Intervention: TPF50 (traditional physical sunscreens SPF 50, liposome-encapsulated DNA repair enzymes complex, antioxidant complex)
Number of subjects: 0
Study 24595577 — intervention group
Group type: COMPARATOR
Intervention: Existing DNA repair and antioxidant and growth factor topical products with SPF 50 sunscreens
Number of subjects: 0
Study 21733926 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Hb threshold transfusions
Number of subjects: 0
Study 21733926 — intervention group
Group type: COMPARATOR
Intervention: Low-Hb threshold transfusions
Number of subjects: 0
Study 21221205 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Suprapubic Cystostomy with Timed Drainage (TSPCD)
Number of subjects: 82
Study 21221205 — intervention group
Group type: COMPARATOR
Intervention: Continuous Suprapubic Cystostomy with Urine Bag (CSPCD)
Number of subjects: 82
Study 16643843 — intervention group
Group type: EXPERIMENTAL
Intervention: Penn Resiliency Program (PRP)
Number of subjects: 168
Study 16243175 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouth rinse
Number of subjects: 25
Study 16243175 — intervention group
Group type: COMPARATOR
Intervention: Sterile saline
Number of subjects: 25
Study 11834781 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid analgesia
Number of subjects: 0
Study 11834781 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo analgesia
Number of subjects: 0
Study 11834781 — intervention group
Group type: COMPARATOR
Intervention: Pain-only condition
Number of subjects: 0
Study 10190764 — intervention group
Group type: EXPERIMENTAL
Intervention: Oramorph SR 30 mg
Number of subjects: 28
Study 10190764 — intervention group
Group type: COMPARATOR
Intervention: MST-30 Mundipharma Retardtabletten
Number of subjects: 28
Study 7480610 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot resource mothers program
Number of subjects: 0
Study 7480610 — intervention group
Group type: COMPARATOR
Intervention: Large-scale service program
Number of subjects: 0
Study 2275325 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia with bupivacaine
Number of subjects: 30
Study 7436160 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosol metaproterenol (5 puffs, 0.65 mg each, total 3.25 mg)
Number of subjects: 17
Study 7436160 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined regimen (oral metaproterenol 20 mg + aerosol metaproterenol)
Number of subjects: 17
Study 7436160 — intervention group
Group type: COMPARATOR
Intervention: Oral metaproterenol (20 mg tablet)
Number of subjects: 17
Study 7436160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 30901356 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum release teat
Number of subjects: 0
Study 30901356 — intervention group
Group type: COMPARATOR
Intervention: Standard teat
Number of subjects: 0
Study 27864607 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 0
Study 27864607 — intervention group
Group type: COMPARATOR
Intervention: Invasive Coronary Angiography (ICA)
Number of subjects: 0
Study 25548838 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (strengthening masticatory effort during the denervated atrophic stage)
Number of subjects: 98
Study 25548838 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (no instruction to strengthen masticatory effort)
Number of subjects: 98
Study 23749293 — intervention group
Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate) 240 mg twice daily (BID)
Number of subjects: 0
Study 23749293 — intervention group
Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate) three times daily (TID)
Number of subjects: 0
Study 23749293 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 0
Study 23749293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20430573 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical ratings by speech-language pathologists (SLPs)
Number of subjects: 99
Study 20430573 — intervention group
Group type: COMPARATOR
Intervention: Laboratory ratings by three experienced SLPs
Number of subjects: 99
Study 20430573 — intervention group
Group type: COMPARATOR
Intervention: Median of the three laboratory ratings
Number of subjects: 99
Study 19221543 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 34
Study 19221543 — intervention group
Group type: COMPARATOR
Intervention: Blended Anesthesia (BA = GA plus epidural analgesia)
Number of subjects: 34
Study 17374057 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosmetics with active ingredient (Group A)
Number of subjects: 50
Study 17374057 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group B)
Number of subjects: 50
Study 15533470 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin
Number of subjects: 100
Study 15533470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 15533470 — intervention group
Group type: EXPERIMENTAL
Intervention: Other treatments
Number of subjects: 100
Study 11124744 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate
Number of subjects: 20
Study 11124744 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 20